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Abstract
Non-human primates such as Chinese rhesus macaques (Ch Rhs) provide good animal models for research on human
infectious diseases. Similar to humans, there are two principal subsets of dendritic cells (DCs) in the peripheral blood of Ch
Rhs: myeloid DCs (mDCs) and plasmacytoid DCs (pDCs). In this study, two-color fluorescence-activated cell sorting (FACS)
analyses were used to identify the main DC subsets, namely CD1c
+ mDCs and pDCs from Ch Rhs. Then, the apoptosis and
immunophenotype changes of DCs subsets were first described during the acute phase of SIVmac239 infection. Both the
DCs subsets showed decreased CD4 expression and enhanced CCR5 expression; in particular, those of pDCs significantly
changed at most time points. Interestingly, the plasma viral loads were negatively correlated with CD4 expression, but were
positively correlated with CCR5 expression of pDCs. During this period, both CD1c
+ mDCs and pDCs were activated by
enhancing expressions of co-stimulatory molecules, accompanied with increase in CCR7. Either CD80 or CD86 expressed on
CD1c
+ mDCs and pDCs was positively correlated with the plasma viral loads. Our analysis demonstrates that the pDCs were
more prone to apoptosis after infection during the acute phase of SIVmac239 infection, which may be due to their high
expressions of CD4 and CCR5. Both DCs subsets activated through elevating the expression of co-stimulatory molecules,
which was beneficial in controlling the replication of SIV. However, a mere broad immune activation initiated by activated
DCs may lead to tragic AIDS progression.
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Introduction
HIV has been studied for more than 27 years, but it is difficult
to understand how the immune systems defend against HIV
infection. As a result, an effective vaccine to cure the AIDS could
not be developed. A suitable animal model is necessary for HIV
study, especially vaccine research and development. Chinese
rhesus macaques (Ch Rhs) have been used extensively in recent
years to resolve the shortage of Indian-origin rhesus macaques (Ind
Rhs), especially in AIDS research. Interestingly, when compared
with Ind Rhs, SIVmac pathogenesis in Ch Rhs has been found to
be closer to HIV-1 infections in untreated adult humans [1].
Therefore, the Ch Rhs have been considered as a suitable AIDS
animal model, and may have advantages over the rapid and highly
pathogenic Ind Rhs’ model.
Dendritic cells (DCs) are essential for innate and adaptive
immunity. In general, DCs patrol around the peripheral tissues of
the human body and execute their duty of antigen uptake, process,
and presentation to naı ¨ve T-cells [2]. DCs are a heterogeneous
population, which differ in location, migratory pathways, immu-
nological function, and so on. According to the origin, DCs are
divided into two main subsets, namely myeloid DCs (mDCs) and
plasmacytoid DCs (pDCs) [3]. mDCs are mostly located in the
outside milieu for the detection of pathogens, and form a direct
link between innate and adaptive immunity [2], while pDCs are
not found in high amounts at sites of pathogen entry. pDCs show a
less effective function with regard to capture and presentation than
mDCs, and are prone to secrete a large amount of cytokines to
influence innate immunity [4].
DCs subsets play a pivotal role in controlling HIV infection
and AIDS progression. In vivo, numerous studies have shown that
the numbers of both mDCs and pDCs are markedly decreased
in the blood of patients infected with HIV-1 during the chronic
phase [5–11], and the DCs are functionally impaired with
respect to T-cell proliferation and cytokine production. A
decrease in mDCs-associated IL-12 [12] or pDCs-associated
IFN-a production [9,11] was evident in HIV-infected subjects in
association with high viral loads and AIDS progression. In vitro,
the interaction between HIV-1 and DCs is very complicated. On
the one hand, both the DCs subsets can be infected by HIV-1
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subsets can be activated by contact with the HIV particles.
Human blood pDCs undergo phenotypic and functional
activation following exposure to HIV, and induce the bystander
maturation of mDCs [14]. The same result that circulating
blood DCs subsets increased the surface expression of co-
stimulatory molecules was also observed in vivo in patients with
HIV-1 viremia [6]. However, the activation was influenced by
HIV and led to an abnormal immune response. The infected
immature MDDCs failed to mature and induced IL-10
production, which caused immune suppression [15].
A large number of evidences demonstrate that chronic,
generalized immune activation is a major determinant of AIDS
progression in pathogenic HIV-1 and SIVmac infections [16]. The
DCs are the initiators of immune activation and are suspected to
be the potential factors of AIDS progression. pDCs can sense
HIV-1 single-stranded RNA via TLR7 and induce activation of
the immune system [17]. It was proved that IFN-a, mainly
secreted by HIV-1-stimulated pDCs, has the central role in
immune activation and influences disease progression. Meier et al.
found that pDCs derived from women produce markedly more
IFN-a in response to HIV-1 than those derived from men, which
may account for higher immune activation in women. Further-
more, HIV-1-infected women tend to have lower viral loads early,
but progress faster to AIDS [18]. Similarly, SIV infection has been
found to trigger a rapid and strong IFN-a response in both rhesus
macaques and African green monkeys (AGMs) in the acute phase,
but only AGMs have been found to effectively control this
response and avoid a pathogenic progression [19]. Thus, the
activation of pDCs may be predictive of the disease outcome.
Our previous study found that SIVmac239-infected Ch Rhs
significantly increased IFN-a and IL-12 production in the acute
Figure 1. Two-color strategy for identifying CD1c
+ mDCs and pDCs. (A) PBMCs (R1) were first gated on Forward-scatter/side-scatter (FSC/
SSC) scattergram. Then, CD1c
+ mDCs (CD1c
+CD14
2CD20
2) were selected in the R2 region and pDCs (CD123
brightHLA-DR
+) were selected in the R3
region. (B) The expressions of immunophenotypes, including CD4, CCR5, CD80, CD83, CD86, and CCR7 on DCs subsets were analyzed. Open
histograms correspond to isotype controls and filled gray histograms correspond to specific mAbs staining.
doi:10.1371/journal.pone.0029036.g001
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activation of DCs subsets [20]. To reveal the in vivo status of the
DCs subsets, we detected the trend of apoptosis and immunophe-
notype of CD1c
+ mDCs and pDCs from Ch Rhs during the acute
phase of SIVmac239 infection, and found that pDCs were more
influenced by SIV infection than CD1c
+ mDCs. This discrepancy
between pDCs and CD1c
+ mDCs shows the different roles of DCs
subsets in AIDS progression.
Results
Phenotypic analysis of Ch Rhs’ CD1c
+ mDCs and pDCs
using two-color flow cytometry
The mDCs and pDCs are very rare in blood. In general, human
mDCs and pDCs can be identified as Lin
2HLA-DR
+CD11c
+ and
Lin
2HLA
-DR
+CD123
+, respectively. In addition, human DCs
also express a group of particular molecules, namely blood
dendritic cells antigen (BDCA). The series of BDCA include
BDCA-1 (CD1c), -2, -3, and -4. However, only CD1c have been
found to show a significant cross-activity with simian PBMCs [21].
CD1c are mainly expressed on the B-lymphocytes and mDCs,
and merely a few on monocytes. Therefore, we used
CD1c
+CD14
2CD20
2 to estimate the mDCs. Earlier studies have
shown that pDCs can be directly recognized as CD123
brightHLA-
DR
+ cells, either from human [22] or simian [23,24]. In our study,
PBMCs (R1, Figure 1A) were first gated appropriately in the
forward-scatter/side-scatter (FSC/SSC) scattergram using FSC as
the threshold. The CD1c
+CD14
2CD20
2 of the PBMCs were
CD1c
+ mDCs (R2, Figure 1A), while CD123
brightHLA-DR
+ were
pDCs (R3, Figure 1A).
Subsequently, the DCs subsets were phenotypically analyzed for
other DC and APC markers to ensure the practicable of DCs
subdivision through two-color flow cytometry. As shown in Table 1,
both CD1c
+ mDCs and pDCs were negative for linage markers,
CD40, CD80, CD83, and DC-SIGN expression, and exhibited low
level of CCR7 expression. CD1c
+ mDCs expressed a high
percentage of CD86, while pDCs expressed low. pDCs lacked
most of the myeloid markers, such as CD11b and CD11c. In
humans, the CD11c
+ mDCs can be subdivided into three different
subsets, namely, CD16
+, CD1c
+, and BDCA-3
+ mDCs [25].
However, the CD1c
+ mDCs of Ch Rhs have been found to show
almost no expression of CD11c. Brown et al. pointed that the
CD11c
+ mDCs of Ind Rhs exhibit no expression of CD1c [26],
similar to our results. It is very different from the SIV-receptors
expressions of CD1c
+ mDCs and pDCs; the pDCs highly expressed
CD4 and CCR5, which were quite low on CD1c
+ mDCs. A
representative experiment for the expression of SIV receptors and
activation markers on DCs subsets is depicted in Figure 1B.
The percentage of pDCs, not CD1c
+ mDCs, showed
transient increase during acute SIVmac239 infection
Four Ch Rhs were infected with SIVmac239, and the viral loads
(Figure 2A) have been described in a previous study [20].
The percentage of CD1c
+ mDCs in PBMCs before infection
was 0.6260.05%, which declined to a nadir (0.3660.14%) at the
day 15 p.i. Then, the value returned and fell again. Furthermore,
CD1c
+ mDCs did not show a significant increase or decrease
during this period (Figure 2B). However, the percentage of pDCs
in PBMCs was significantly increased at days 6 (0.2360.08%,
P=0.05) and 34 (0.2660.08%, P=0.046), compared with the
normal value (0.1260.05%) before infection. These increases may
be due to the migration of the pDCs into the blood and the loss of
CD4
+ T-cells (Figure 2C).
Increased apoptosis of pDCs, not CD1c
+ mDCs, during
acute SIVmac239 infection
In our previous study, we found that the absolute numbers of both
the DCs subsets decreased to a nadir at day 15 p.i [20]. A potential
mechanism for this phenomenon could be a high rate of cell death.
Therefore, simian PBMCs stained with Annexin V were used to
identify the DCs subsets undergoing apoptosis. Before infection, the
percentage of Annexin V positive CD1c
+ mDCs (31.764.0%) was
obviously higher than apoptotic pDCs (1.460.5%). However, the
apoptosis of CD1c
+ mDCs was not significantly alter during the acute
phase of infection, despite the fact that there was a little increase on
most of the days, when compared with the day before infection
(Figure 3A). Apoptosis of pDCs was significantly influenced by
SIVmac239 infection. When compared with pre-infection, the
percentage of Annexin V positive pDCs significantly increased at
days 15 (6.061.8%, P=0.05) and 34 p.i (16.061.0%, P=0.001)
(Figure 3B). This demonstrates that the virus selectively induced
apoptosis of pDCs, rather than CD1c
+ mDCs.
Effect of SIVmac239 on blood CD1c
+ mDCs and pDCs
expression of CD4 and CCR5 during acute infection
Most of the studies have shown that the isolated blood DCs
subsets expressed CD4 and CCR5, and can be directly infected by
HIV [13,27]. Simian DCs subsets also expressed these SIV
receptors [28,29]. As shown in Figure 1B, CD1c
+ mDCs from Ch
Rhs had a low expression of CD4 and CCR5. However, almost all
pDCs expressed CD4 and CCR5, which seem to imply that the
Table 1. Phenotypic analysis of CD1c
+ mDCs and pDCs
subsets identified by two-color flow cytometry.
Marker CD1c
+ mDC pDC
Lineage
CD3 2 2
CD8 2 2
CD14 2 2
CD16 2 2
CD20 2 2
APCs
CD40 2 2
CD80 2 2
CD83 2 2
CD86 + 2/+
HLA-DR + +
Integrins
CD11b 2/+ 2
CD11c 2/+ 2
HIV receptor
CD4 2/+ +
CCR5 2/+ +
DC-SIGN 2 2
Migration
CCR7 2/+ 2/+
2: negative expression (less than 1% positive cells).
2/+: marginal positive expression (less than 30% positive cells).
+: positive expression (more than 90% positive cells).
doi:10.1371/journal.pone.0029036.t001
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loads in SIVmac239-infected Ch Rhs; (B) Blood CD1c
+ mDCs percentages in PBMCs during the infection; (C) Blood pDCs percentages in PBMCs during
the infection.
doi:10.1371/journal.pone.0029036.g002
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+
mDCs. Subsequently, the mean fluorescence intensities (MFI) of
CD4 and CCR5 expressed on both CD1c
+ mDCs and pDCs were
observed during the acute SIVmac239 infection (Figure 4A).
Because of the low percentage of CD4 and CCR5 expression, the
CD1c
+ mDCs showed a low MFI of both CD4 and CCR5 which
represented a background staining. The MFI of CD1c
+ mDCs’
CD4 was not obviously changed. The expression of CCR5 on
CD1c
+ mDCs increased at day 10, but was not significant. On the
other hand, pDCs those highly expressed CD4 and CCR5 were
prone to be influenced by SIV infection. At the baseline, the value
of pDCs’ CD4 MFI was 21.1861.93, which was significantly
decreased at days 3 (16.7762.83, P=0.039), 6 (16.0563.29,
P=0.049), 15 (11.3761.59, P=0.05), 19 (12.0662.18, P=0.002),
27 (14.5561.89, P=0.001), 34 (15.5860.96, P=0.01), and 62
(12.3463.05, P=0.028) p.i. This indicates that the SIVmac239
infection downregulated the expression of CD4 on pDCs. On the
contrary, the CCR5 MFI of pDCs was significantly increased at
days 6 (84.05613.13, P=0.018), 10 (127.29617.39, P=0.01), 15
(115.77614.54, P=0.005), 19 (155.48621.87, P=0.005), 27
(169.10628.59, P=0.013), 34 (92.2069.15, P=0.001), and 62
(85.95615.01, P=0.039) p.i from the basic value (47.3368.26).
This was propitious to mobilizing the migration of pDCs to the
infected sites and increasing the probability of infection by SIV.
Subsequently, the correlations between the dynamics of CD4 or
CCR5 expression on both the DCs subsets and virus loads were
analyzed (Figure 4B). There were no statistical correlations
between CD4 and CCR5 expression on CD1c
+ mDCs and virus
loads during infection. However, the CD4 expression on pDCs
was negatively correlated with the viral loads (r=20.365,
P=0.02), while the CCR5 expression on pDCs was positively
correlated with the viral loads (r=0.461, P=0.003).
Effect of SIVmac239 on blood CD1c
+ mDCs and pDCs
expression of co-stimulatory molecules during acute
infection
When activated, the DCs upregulated the expression of co-
stimulatory molecules, such as CD80 and CD86 [2]. In vitro, the
HIV particles, irrespective of whether active or inactive, stimulated
the DCs subsets to upregulate the expressions of co-stimulatory
molecules [30,31]. In normal Ch Rhs, the CD1c
+ mDCs expressed
low CD80 and moderate CD86, and pDCs expressed low CD80
and CD86 (Figure 1B). Furthermore, both the DCs subsets
presented an immature status.
During the acute SIVmac239 infection, the percentage of
CD80
+ CD1c
+ mDCs increased from 1.3660.24% to the peak at
day 10 (15.2568.61%) and sustained a high percentage till day 19
(3.9360.48%), and showed a significant increase at day 19
(P=0.011). The CD86
+ CD1c
+ mDCs maintained a high
percentage all the time and showed no obvious change
(Figure 5A). The percentage of CD80
+ pDCs also increased to a
peak at day 15 (16.0963.70%) and showed a significant increase
at day 48 (13.4462.35%, P=0.021), when compared with that
before infection (4.0761.19%). Similarly, the percentage of
CD86
+ pDCs presented an ascending trend and achieved a peak
at day 15 (23.1164.53%) p.i (Figure 5A). Through the analysis of
correlation, both CD80
+ pDCs (r=0.462, P=0.003) and CD86
+
pDCs (r=0.359, P=0.023) were found to show a positive
correlation with the time of infection, which seems to imply that
more and more pDCs are activated following disease progression.
This phenomenon was not found in CD1c
+ mDCs. However, both
the percentage of CD80
+ pDCs and CD86
+ pDCs decreased at
day 6, which may be related to the rapid influx of fresh pDCs into
the blood, as described in previous studies [20,32].
Further, the analysis of correlations between the expression of
co-stimulatory molecules on DCs subsets and virus loads was
carried out (Figure 5B). While the percentage of CD86
+ CD1c
+
mDCs was not correlated with the viral loads, the percentage of
CD80
+ CD1c
+ mDC (r=0.469, P=0.002), CD80
+ pDC
(r=0.409, P =0.009), and CD86
+ pDC (r=0.422, P =0.007)
were positively correlated with the viral loads. Noticeably, the
expression of CD86 on CD1c
+ mDCs was not only high, but also
showed increased value of MFI (Figure 6A). Interestingly, the MFI
of CD86 on CD1c
+ mDCs also showed a positive correlation with
the virus loads (r=0.352, P=0.026) (Figure 6B).
Effect of SIVmac239 on blood CD1c
+ mDCs and pDCs
migration during acute infection
Once activated by virus, the DCs were found to undergo
progressive maturation and migration, and the migrated DCs
Figure 3. The dynamics of CD1c
+ mDCs and pDCs apoptosis in Ch Rhs during primary SIVmac239 infection. (A) The percentages of
apoptotic CD1c
+ mDCs in PBMCs during infection; (B) The percentages of apoptotic pDCs in PBMCs during infection.
doi:10.1371/journal.pone.0029036.g003
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expressed less than 10% of CCR7 (Figure 1B). As shown in
Figure 7A, the percentage of CCR7
+ CD1c
+ mDCs obviously
increased and showed a significant increase at days 48
(12.7463.56%, P=0.021) and 62 (6.5361.60%, P=0.043) p.i,
when compared with that during pre-infection (2.4061.71%),
while the percentage of CCR7
+ CD1c
+ mDCs was negatively
correlated with that of CD1c
+ mDCs in PBMCs (r=20.375, P
=0.017). The percentage of CCR7
+ pDCs obviously increased at
day 6, but it was not significant, because just two of the four Ch
Rhs showed elevated expression of CCR7 (#04029: 71.82%;
#05049: 45.83%; Figure 7B). In addition, neither the percentage
of CCR7
+ CD1c
+ mDCs nor CCR7
+ pDCs was correlated with
the virus loads.
Discussion
SIV-infected non-human primates can simulate the pathogen-
esis of HIV infection, and were popularly used all over the world.
Now, non-human primates/AIDS models can be divided into two
groups, namely, the nonpathogenic SIV infection in natural hosts
(Sooty mangabey and AGMs) and the pathogenic SIV infection in
rhesus macaques and cynomolgus macaques. A large and growing
body of evidence suggests that a chronic, generalized immune
activation is a major determinant of disease progression in
pathogenic SIVmac infection, similar to humans [33]. The natural
hosts routinely maintain a low level of immune activation, which
prevents chronic immune exhaustion and progression to AIDS
[34].
The DCs play a pivotal role in initiating the immune activation.
In this study, we analyzed the effect of plasma viremia on
apoptosis and immunophenotype of DCs subsets in acute
SIVmac239 infection of Ch Rhs. Through two-color flow
cytometry, we gated the mDCs using CD1c
+CD14
2CD20
2.A s
a myeloid marker, CD1c belongs to the CD1 family, which
mediates lipid presentation. Later, studies have pointed out that a
specific blood mDC marker, namely BDCA-1, is CD1c. Besides
BDCA-1, there are three other BDCA proteins expressed on the
DCs subsets. However, only the antibody of BDCA-1 can cross-
react with rhesus macaques [21]. The CD1c are mainly expressed
on mDCs and B-lymphocytes. However, a little amount of the
simian CD1c are expressed on the monocytes, and hence, we
added the CD14 antibody to eliminate its influence. Piccioli et al.
[25] divided the Lin
2HLA
2DR
+CD11c
+ mDCs from humans
into CD1c, CD16, and BDCA-3 mDCs; however, the same mDCs
from Ind Rhs do not express CD1c [26]. Our results also showed
that the CD1c
+ mDCs from Ch Rhs expressed low level of CD11c,
indicating that the CD1c
+ mDCs are different from the traditional
CD11c
+ mDCs in Ch Rhs. CD123
brightHLA-DR
+ can be directly
used to identify the pDCs, described in human [22] and simian
[23,24] researches. Furthermore, immunophenotype detection has
demonstrated that both the DCs subsets showed no expressions of
lineage markers. Therefore, the two-color method can be used to
identify the DCs subsets. The expressions of CD4 on human
mDCs and pDCs were found to be high, while that of CCR5
presented a controversial conclusion in different studies [8,13,35].
In Ch Rhs, CD1c
+ mDCs expressed low level of CD4 and CCR5,
which were different from human and simian CD11c
+ DCs, and
hence, they may be a new subset of mDCs. The expressions of
CD4 and CCR5 on pDCs of Ch Rhs were similar to those of Ind
Rhs [28]. According to the SIV receptors, it is obvious that pDCs
are more susceptible to SIV infection than CD1c
+ mDCs. It has
been confirmed that an increased percentage of Annexin V
+ pDCs
is significant during acute SIVmac239 infection, when compared
with that of pre-infection, while no significant change could be
found in CD1c
+ mDCs.
After infection, the MFI of CD4 on DCs subsets showed a
tendency to decrease, while that of CCR5 showed a contrary
tendency to increase. At most of the days, the CD4 and CCR5
expressed on pDCs showed significant changes, when compared
with that during pre-infection. It is already known that CD4 is the
receptor of HIV/SIV. After the establishment of productive
infection, the presence of CD4 has been found to disrupt the life
cycle of the virus, including the possibility of super-infection,
premature binding of CD4 to nascent virus particles, and
inhibition of virus release [36]. However, virus has overcome
these problems by downregulating CD4 expression and/or
degrading the newly synthesized CD4 protein. An earlier paper
has pointed out that Nef of HIV mediated the internalization of
the surface CD4 into the endosomes and transferred them to
lysosomes for degradation after HIV infection [37]. In vivo, Barron
et al. [6] found that both the absolute number and percentage of
CD4
+ DCs in Lin
-HLA-DR
+ cells were significantly decreased in
HIV-infected patients, and the percentage of CD4
+ DCs was
negatively correlated with the plasma HIV RNA; however, this
was not significant when detecting the mDCs and pDCs,
respectively. In our study, the MFI of CD4 on pDCs was
negatively correlated with the virus loads, which indicated that the
increase in the virus load leads to more and more infected pDCs
downregulating the CD4 expression. However, this correlation
was not found in CD1c
+ mDCs CD4 expression.
The CCR5 expression increased along with the disease
progression. In vitro, HIV Nef mediated CCR5 endocytosis and
degradation [38]. In addition, the DCs downregulated the CCR5
expression and upregulated the CCR7 expression after being
stimulated by HIV [39]. In vivo, Barron et al. [6] pointed out that
the MFI of mDCs CCR5 was higher in HIV-infected patients,
while that of pDCs showed no difference. However, in another
study, Almeida et al. [5] found that both the percentage and MFI
of CCR5 expressed on pDCs were significantly lower in HIV
progressors. During the acute phase of infection, the MFI of pDCs
CCR5 significantly increased at most of the infectious time points,
which was different from the results observed on humans. This
may be due to the different period of samples collection.
Noticeably, the increase in the CCR5 intensity was observed to
be accompanied by an increased probability of infection. It has
been reported that the intensity of CCR5 expressed on CD4
+ T-
cells determines the virus load in HIV-1-infected persons, and that
there is a strong positive correlation between HIV RNA plasma
level and CCR5 density without cell activation and HIV-induced
CCR5 upregulation [40]. This phenomenon was also observed in
SIVmac239-infected Ch Rhs, where the MFI of pDCs CCR5 was
positively correlated with the virus loads. However, the intensity of
CD4
+ T-cells CCR5 was not decreased after highly active
antiretroviral therapy (HAART) [40], which indicates that the
elevation of CCR5 leads to increase in the virus load, and not vice
Figure 4. Dynamics of SIV receptor expression on CD1c
+ mDCs and pDCs during primary SIVmac239 infection and their
associations with plasma viral loads. (A) Sequential changes of the MFI of CD1c
+ mDCs CD4, CD1c
+ mDCs CCR5, pDCs CD4, and pDCs CCR5 after
SIVmac239 infection. (B) Analysis of correlations between plasma viral loads and the MFI of CD1c
+ mDCs CD4, CD1c
+ mDCs CCR5, pDCs CD4, and
pDCs CCR5. NS: not significant.
doi:10.1371/journal.pone.0029036.g004
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HIV/SIV, but also the ligand of chemokine CCL5 that may
promote the DCs migrating to the inflammatory sites after
stimulation [4]. HIV-Infected pDCs can secrete high level of
RANTES/CCL5 [35], and hence, there an increased concentra-
tion of CCL5 secreted by SIV-infected pDCs might induce other
normal pDCs to upregulate CCR5 and migrate to the infectious
sites, leading to more and more infected pDCs.
Subsequently, we detected the influence of plasma virus loads
on DCs’ activation and migration. The normal blood DCs
maintained an immature status and expressed low co-stimulatory
molecules. In vitro, HIV infection can induce pDCs to upregulate
the expression of CD80, CD86, and CCR7, and promote the
bystander maturation of mDCs by secreting a large amount of
IFN-a [14]. Similarly, increased surface expression of co-
stimulatory molecules was observed on both the DCs subsets in
HIV-1 infected patients. Barron et al. pointed out that
Lin
2HLA
2DR
+ DCs expressed more CD86 and CD40 in HIV-
1-infected viremic subjects, and the MFI of CD86 was positively
correlated with the plasma HIV RNA levels, while negatively
correlated with CD4
+ T-cells counts [6]. Subsequently, Dillon
et al. [41] showed a partial activation of circulating DCs from
viremic HIV-1-infected donors. Although the expression levels of
CD40, CD83, and CD86 on DCs subsets increased, only the
mDCs CD40 expression presented a significant change. The
CD40 expression on both mDCs and pDCs was positively
correlated with the virus loads. In our study, the expression of
CD80 and CD86 on both CD1c
+ mDCs and pDCs also increased
between days 10 and 15 p.i. Except CD86
+ CD1c
+ mDCs, the
percentage of CD80
+ CD1c
+ mDCs, CD80
+ pDCs, and CD86
+
pDCs was positively correlated with the virus loads. Further
analysis showed that the MFI of CD86
+ CD1c
+ mDCs was also
positively correlated with the virus loads. These results indicate
that the DCs subsets are activated during the acute phase of
infection and migrate to the lymph nodes for initial immune
response. However, the DCs in the lymph nodes were found to
undergo incomplete maturation and exhibit reduced expression of
CD80 and CD86 [42,43]. In Ind Rhs with AIDS, this activation of
blood DCs subsets was not observed, indicating impaired
activation of DCs in the late phase [44]. The CCR7 expression
accompanied by the activation was significant on the CD1c
+
mDCs. The CCR7 on pDCs increased to a peak at day 6 p.i,
which is earlier than that in Ind Rhs [45].
In summary, our study focused on the influence of SIVmac239
on the status of DCs subsets from Ch Rhs during the acute phase
of infection. The results revealed that the pDCs were more prone
to apoptosis after infection, which may be due to their high
expressions of CD4 and CCR5. Both the DCs subsets showed
decreased CD4 expression and enhanced CCR5 expression;
particularly, those of pDCs significantly changed at most of the
time points. The MFI of CD4 expressed on pDCs was negatively
correlated with the plasma viral loads, while the MFI of CCR5
was positively correlated. However, no correlation was found in
CD1c
+ mDCs. During this period, the percentage of active CD1c
+
mDCs and pDCs obviously increased, following an increase in
CCR7. Either CD80 or CD86 expressed on CD1c
+ mDCs and
pDCs was positively correlated with the plasma viral loads. The
activation of DCs was found to be beneficial in controlling the
replication of SIV. However, a mere broad immune activation
initiated by activated DCs may lead to tragic AIDS progression.
Materials and Methods
Animals
Ethics Statement. All animal and in vitro procedures were
performed using standard protocols and according to guidelines
approved (Approval number: 20070430) by the Ethics Committee
of Kunming Institute of Zoology, Chinese Academy of Sciences in
accordance with the recommendations of the Weatherall report.
"The use of non-human primates in research".
Figure 6. The effects of SIV on the MFI of CD1c
+ mDC CD86 after SIVmac239 infection. (A) The dynamics of CD86 MFI on CD1c
+ mDCs; (B)
Analysis of correlation between plasma viral loads and the MFI of CD1c
+ mDCs CD86.
doi:10.1371/journal.pone.0029036.g006
Figure 5. Dynamics of co-stimulatory molecules expression on CD1c
+ mDCs and pDCs during primary SIVmac239 infection and
their associations with plasma viral loads. (A) Sequential changes of the percentage of CD1c
+ mDCs CD80, CD1c
+ mDCs CD86, pDCs CD80, and
pDCs CD86 after SIVmac239 infection. (B) Analysis of correlations between plasma viral loads and the percentage of CD1c
+ mDCs CD80, CD1c
+ mDCs
CD86, pDCs CD80, and pDCs CD86. NS: not significant.
doi:10.1371/journal.pone.0029036.g005
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Kunming Primate Research Center, Chinese Academy of Sciences
(CAS). Naı ¨ve animals were screened and found to be negative for
simian type D retrovirus (SRV) and SIV using antibody ELISA and
PCR prior to use. All the four Ch Rhs (05049, 04029, 04039, and
01035) were inoculated intravenously with 5610
3 50% tissue
culture infectious doses of SIVmac239, and observed only during
the early phase of infection, probably 62 days p.i.
Viral loads
The levels of viral RNA in plasma were measured by an in-
house real-time PCR method as previously described [20].
Flow cytometric analysis
Two-color fluorescence-activated cellsorting(FACS) analysis was
used to identity the DCs subsets. Unlike the common method,
CD1c
+CD14
2CD20
2 were used to gate the CD1c
+ mDCs, and
CD123
brightHLA-DR
+ were used to gate the pDCs. Subsequently,
the immunophenotype of mDCs and pDCs from whole blood
samples of naı ¨ve and SIV-infected monkeys was detected by three-
color flow cytometry using the residual fluorescent channel. In brief,
the whole blood (100 ml) was incubated with the appropriate
monoclonal antibodies against CD1c (clone AD5-8E7; Miltenyi),
CD3e (clone SP34; BD), CD4 (clone MT-466; Miltenyi), CD8
(clone BW/135/80; Miltenyi), CD11b (clone M1/70.15.11.5;
Miltenyi), CD11c (clone 3.9; eBioscience), CD14 (clone M5E2;
Biolegend), CD14 (clone TU ¨K4; Miltenyi), CD16 (clone VEP13;
Miltenyi), CD20 (clone 2H7; Biolegend), CD20 (clone LT20;
Miltenyi), CD40 (clone 5C3; BD), CD80 (clone L307.4; BD), CD83
(clone HB15e; BD), CD86 (clone FUN-1; BD), CD123 (clone 7G3;
BD), CD209 (clone 120507; R&D), CCR5 (clone 3A9; BD), CCR7
(clone 150503; R&D), HLA-DR (clone G46-6; BD), and HLA-DR
(clone L243; BD) for 15 min at room temperature. Then, 1 ml of
FACS lysing solution (BD Biosciences) was added to each sample to
lysetheredbloodcellsandfixthesamples.Theremainingcellswere
washed at 5006g for 5 min. The cell pellet was re-suspended in
Dulbecco’s PBS with BSA (DPBS-BSA BD) for flow cytometric
analysis. Appropriate isotype-matched control antibodies were used
in all the labeling experiments. Almost 300,000 events of each
sample were acquired through the FACS Calibur flow cytometer
(Becton Dickinson) and analyzed using CellQuest software.
Apoptosis detection of DCs subsets
Simian peripheral blood mononuclear cells (PBMCs) were
isolated from monkeys by Ficoll-Paque (GE Healthcare) density
gradient centrifugation and adjusted to 1610
7 cells/ml. And 1610
6
cells were precipitated and re-suspended in 100 ml of DPBS-BSA. A
mixture of antibodies used to identify mDCs (CD1c/CD14/CD20)
and pDCs (CD123/HLA-DR) were added. After incubating in the
dark for 30 min at 4uC, simian PBMCs were washed and stained
with Annexin V (Bender MedSystems) in binding buffer for another
10 min. The apoptosis of DCs subsets were detected and analyzed
using an FACS Calibur flow cytometer.
Statistical analysis
All data were analyzed using SPSS 13.0 software. Baseline and follow-
up data were compared using the paired t-test or Wilcoxon matched-
pairs test, according to the distribution of the variables analyzed by
Shapiro-Wilk test. The nonparametric Spearman’s rank correlation test
was used to investigate the relationship between the parameters. For all
the tests, two-sided p,0.05 was considered to be significant.
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